No Differences in Levels of Circulating Progenitor Endothelial Cells or Circulating Endothelial Cells Among Patients Treated With Ticagrelor Compared With Clopidogrel During Non–ST‐Segment–Elevation Myocardial Infarction

No Differences in Levels of Circulating Progenitor Endothelial Cells or Circulating Endothelial Cells Among Patients Treated With Ticagrelor Compared With Clopidogrel During Non–ST‐Segment–Elevation Myocardial Infarction

Background Ticagrelor use during acute coronary syndromes demonstrated a decrease in all‐cause mortality in the PLATO (Platelet Inhibition and Patient Outcomes) trial. This effect has been attributed to a non–platelet‐derived improvement in endothelial function. The aim of this study was to determin...

Full description

Bibliographic Details
Main Authors: Alejandro Diego‐Nieto, Maria B. Vidriales, Norberto Alonso‐Orcajo, Jose C. Moreno‐Samos, Francisco Martin‐Herrero, Raul Carbonell, Belen Cid, Ignacio Cruz‐Gonzalez, Javier C. Martin‐Moreiras, Carlos Cuellas, Cristina Pascual, Maria Lopez‐Benito, Pedro L. Sanchez, Felipe Fernandez‐Vazquez, Armando Perez de Prado
Format: Article
Language:English
Published: Wiley 2018-10-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
circulating endothelial cells
endothelial progenitor cells
ticagrelor
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.118.009444

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.118.009444

Similar Items